The direct binding of aPL antibodies to brain tissue, the relationship between the titer of aPL and the degree of cognitive impairment, and the mononuclear inflammatory infiltrate in brain tissue, all suggest a direct effect of aPL antibodies on brain tissue through an inflammatory mechanism, the nature of which remains to be determined. The gene discussed is FASLG; the disease is Cognitive impairment.